Induction chemotherapy with carboplatin and paclitaxel followed by radiotherapy and concurrent weekly carboplatin plus paclitaxel in locally advanced nasopharyngeal carcinoma in a nonendemic population

被引：3
|
作者：
Numico, G.
Airoldi, M.
Gabriela, P.
Gabriele, A.
Garzaro, M.
Raimondo, L.
Pedani, F.
Beatrice, F.
Pecorari, G.
Giordano, C.
机构：
[1] Osp Reg Valle DAosta, Aosta, Italy
[2] San Giovanni Antica Sede Hosp, Turin, Italy
[3] Candiolo Canc Inst, Radiat Therapy Div, Turin, Italy
[4] San Giovanni Antica Sede Hosp, Radiat Therapy Div, Turin, Italy
[5] Univ Turin, Physiopathol Dept, ENT Div 1, Turin, Italy
[6] San Giovanni Antica Sede Hosp, Dept Med Oncol, Turin, Italy
[7] San Giovanni Bosco Hosp, ENT Dept, Turin, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5569
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical Outcome And Toxicity Of Induction Followed By Definitive Concurrent Chemoradiotherapy With Weekly Paclitaxel Plus Carboplatin In Squamous Cell Carcinoma Of Esophagus Unsuitable For Surgery
    Rastogi, M.
    Gandhi, A. K.
    Singh, H. B.
    Nanda, S. S., Sr.
    Rath, S.
    Khurana, R.
    Hadi, R.
    Mishra, S. P.
    Srivastva, A. K.
    Bharati, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E662 - E663
  • [32] Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma - A Hellenic Cooperative Oncology Group Phase II Study
    Fountzilas, G
    Tolis, C
    Kalogera-Fountzila, A
    Karanikiotis, C
    Bai, M
    Misailidou, D
    Samantas, E
    Athanassiou, E
    Papamichael, D
    Tsekeris, P
    Catodritis, N
    Nicolaou, A
    Plataniotis, G
    Makatsoris, T
    Papakostas, P
    Zamboglou, N
    Daniilidis, J
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (04) : 223 - 230
  • [33] A phase II study of dose-dense neoadjuvant chemotherapy with weekly paclitaxel and carboplatin followed by chemoradiation in locally advanced cervical carcinoma.
    Singh, Rajkumar Bikramjit
    Kumar, Lalit
    Chandra, Subhash
    Mohanti, B. K.
    Pathy, Sushmita
    Kumar, K. Sunesh
    Bhatla, Neerja
    Thulkar, Sanjay
    Vishnubhatla, Sreenivas
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Decreased distant recurrence and preserved local control using dose dense induction weekly paclitaxel (P) and carboplatin (C) followed by concurrent paclitaxel, carboplatin and radiotherapy (CRT) in locally advanced head and neck squamous cell cancers (HN-SCC).
    Nadeem, A
    Desai, S
    Chougule, P
    Wanebo, H
    Ruhl, C
    Joyce, D
    Tarro, J
    Kennedy, T
    Ready, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 499S - 499S
  • [35] Induction chemotherapy with weekly cetuximab, carboplatin, and paclitaxel in the treatment of locally advanced head and neck cancer: The University of Pennsylvania experience
    Bauman, Jessica R.
    Langer, Corey J.
    Quon, Harry
    Algazy, Kenneth M.
    Desai, Arati Suvas
    Mutale, Faith
    Lin, Alexander
    Weiss, Jared
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Phase II study of induction carboplatin and paclitaxel followed by thoracic radiotherapy and concurrent daily cisplatin plus weekly paclitaxel in inoperable non-small-cell lung cancer (NSCLC)
    Tixi, L
    Grossi, F
    Scolaro, T
    Bacigalupo, A
    Ardizzoni, A
    Cafferata, MA
    Vitale, V
    Rosso, R
    ANNALS OF ONCOLOGY, 2000, 11 : 11 - 11
  • [37] Induction chemotherapy with paclitaxel, carboplatin and cetuximab for locoregionally advanced nasopharyngeal carcinoma: A single-center, retrospective study
    Takeshita, Naohiro
    Enokida, Tomohiro
    Okano, Susumu
    Fujisawa, Takao
    Wada, Akihisa
    Sato, Masanobu
    Tanaka, Hideki
    Tanaka, Nobukazu
    Motegi, Atsushi
    Zenda, Sadamoto
    Akimoto, Tetsuo
    Tahara, Makoto
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinoma
    Fukuda, Minoru
    Obase, Yasushi
    Miyashita, Naoyuki
    Kobashi, Yoshihiro
    Mohri, Keiji
    Ueno, Shiro
    Hayama, Makio
    Shimizu, Katsuhiko
    Nishimura, Hironori
    Nakata, Masao
    Oka, Mikio
    ANTICANCER RESEARCH, 2007, 27 (3B) : 1601 - 1604
  • [39] Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
    Dessai, S. B.
    Chakraborty, S.
    Babu, T. V. S.
    Nayanar, S.
    Bhattacharjee, A.
    Jones, J.
    Balasubramanian, S.
    Patil, Vijay M.
    SOUTH ASIAN JOURNAL OF CANCER, 2016, 5 (02) : 63 - +
  • [40] Adjuvant carboplatin and paclitaxel after concurrent cisplatin and radiotherapy in patients with locally advanced cervical cancer
    Yavas, Guler
    Yavas, Cagdas
    Sen, Erdem
    Oner, Irem
    Celik, Cetin
    Ata, Ozlem
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (01) : 42 - 47
12345